JPMORGAN CHASE & CO

Holdings History for ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)

Symbol: SPRY on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$4,859,098	417,090	+382,031	+1090%	$11.65	Q4 2025
30 Sep 2025	0%	0%	$352,343	35,059	+499	+1.4%	$10.05	Q3 2025
30 Jun 2025	0%	+0%	$603,071	34,560	+2,357	+7.3%	$17.45	Q2 2025
31 Mar 2025	0%	+0%	$405,114	32,203	+1,091		$12.58	Q1 2025
31 Dec 2024	0%	-0%	$328,232	31,112	-1,710	-5.2%	$10.55	Q4 2024
30 Sep 2024	0%	0%	$475,919	32,822	-178	-0.54%	$14.50	Q3 2024
30 Jun 2024	0%	-0%	$280,830	33,000	-17,183	-34%	$8.51	Q2 2024
31 Mar 2024	0%	+0%	$512,870	50,183	+15,534	+45%	$10.22	Q1 2024
31 Dec 2023	0%	0%	$189,877	34,649	+369	+1.1%	$5.48	Q4 2023
30 Sep 2023	0%	+0%	$129,578	34,280	+11,746	+52%	$3.78	Q3 2023
30 Jun 2023	0%	+0%	$150,978	22,534	+19,612	+671%	$6.70	Q2 2023
31 Mar 2023	0%	0%	$19,000	2,922	+350	+14%	$6.50	Q1 2023
31 Dec 2022	0%	+0%	$22,000	2,572	+461	+22%	$8.55	Q4 2022
30 Sep 2022	0%	0%	$11,000	2,111	+614	+41%	$5.21	Q3 2022
30 Jun 2022	0%	-0%	$6,000	1,497	-12,261	-89%	$4.01	Q2 2022
31 Mar 2022	0%	-0%	$49,000	13,758	-158,066	-92%	$3.56	Q1 2022
31 Dec 2021	0%	+0%	$1,144,000	171,824	+122,182	+246%	$6.66	Q4 2021
30 Sep 2021	0%	+0%	$495,000	49,642	+40,547	+446%	$9.97	Q3 2021
30 Jun 2021	0%	-0%	$281,000	9,095	-19,255	-68%	$30.90	Q2 2021
31 Mar 2021	0%	+0%	$1,237,000	28,350	+28,350	NEW	$43.63	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.